M12.569 Insurance Policy Changes

ICD-10 M12.569 is officially defined as "Traumatic arthropathy, unspecified knee." code M12.569 is referenced in 5 tracked payer policy changes from Excellus BlueCross BlueShield, Aetna, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code M12.569 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Excellus BlueCross BlueShield · Effective Jan 1, 2027Medium impact
Orthopedic Joint Procedures of the Knee for Managed Medicaid (MMC), Health and Recovery Plan (HARP), Child Health Plus (CHP), and Essential Plan (EP) Members - (Effective Date - 2027-01-01) 7.01.123
Excellus BlueCross BlueShield medical policy 7.01.123 sets the medical necessity criteria for knee joint procedures for Managed Medicaid (MMC), Health and Recovery Plan (HARP), Child Health Plus (CHP), and Essential Plan (EP) members. The current effective date is January 1, 2027. The policy covers total, revision and partial knee arthroplasty, patellofemoral arthroplasty, diagnostic and surgical knee arthroscopy, chondroplasty, debridement, ligament reconstruction and repair, meniscal procedures, patellar realignment, lysis of adhesions, manipulation under anesthesia, and restorative cartilage procedures, each with its own criteria. The policy history shows a 10/22/26 off-cycle update that removed site of service criteria.
Excellus BlueCross BlueShield · Effective Oct 15, 2026Medium impact
Autologous Chondrocyte Implantation (ACI) - (Effective Date - 2026-10-15) 7.01.38
Excellus BlueCross BlueShield medical policy 7.01.38 on autologous chondrocyte implantation (ACI), using the matrix-induced ACI (MACI) implant, has a current effective date of October 15, 2026. ACI is considered medically appropriate for individuals aged 15 to 55 with a BMI of 35 or less, no inflammatory arthritis, Kellgren-Lawrence Grade II or less on radiographs, and a full-thickness distal femoral or patellar chondral defect of 1 to 10 cm2 identified by CT arthrogram, by MRI with Modified Outerbridge Grade III or IV, or by arthroscopy with Outerbridge Grade III or IV. The policy also requires function-limiting knee pain and at least three months of failed provider-directed, non-surgical management, and it considers ACI not medically necessary for several other indications, including any knee joint surgery within six months before screening and cruciate ligament instability. Hybrid ACI performed with osteochondral autograft transfer is considered investigational for osteochondral defects.
Aetna · Identified Aug 16, 2026Medium impact
Seat Lifts and Patient Lifts (CPB 0459, reviewed 2026-07-16)
Aetna covers seat lift mechanisms as durable medical equipment only when the member cannot stand up from a regular armchair at home, has severe arthritis of the hip or knee or severe neuromuscular disease, the device is prescribed to effect improvement or arrest or slow deterioration, and the member can ambulate once standing. Stand-assist lifts, patient lifts, bariatric lifts, and multi-positional transfer systems are covered only when their own separate criteria are met, and spring-release seat lifts with a catapult-type motion are considered experimental, investigational, or unproven. the policy was last reviewed 07/16/2026.
Blue Cross & Blue Shield of Mississippi · Identified Jun 20, 2026Medium impact
Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis
Postsurgical home use of limb compression devices for venous thromboembolism (VTE) prophylaxis may be considered medically necessary in individuals with a contraindication to pharmacologic agents after major orthopedic surgery (total hip arthroplasty, total knee arthroplasty, hip fracture surgery), or after major nonorthopedic surgery or other orthopedic procedures in individuals at moderate or high risk of VTE. It is considered investigational in all other situations, including after major orthopedic surgery in individuals without a contraindication for anticoagulation, and for periods longer than 30 days post-surgery. Federal Employee Program may dictate that FDA-approved devices may be assessed only on the basis of their medical necessity.
Aetna · Identified Aug 15, 2026Low impact
Extracorporeal Shock-Wave Therapy for Musculoskeletal Indications and Soft Tissue Injuries (CPB 0649, reviewed 2025-10-02)
This is Aetna Clinical Policy Bulletin 0649, reviewed October 2, 2025 and first found by PolicyChanges in August 2026, so it is historical material and the current version should be confirmed before acting. Aetna covers extracorporeal shock-wave therapy only for calcific tendinopathy of the shoulder with a calcium deposit of at least 1 cm lasting 6 months or more after conservative care has failed, and lists dozens of other musculoskeletal, wound and medical uses as experimental, investigational or unproven.

Watch M12.569

Get one email when a payer policy names M12.569, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

FREQUENTLY ASKED QUESTIONS

What insurance policy changes affect code M12.569?

There are 5 tracked policy changes affecting code M12.569, including updates from Excellus BlueCross BlueShield, Aetna, Blue Cross & Blue Shield of Mississippi. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code M12.569?

Payers that have issued tracked updates for code M12.569 include: Excellus BlueCross BlueShield, Aetna, Blue Cross & Blue Shield of Mississippi.

How do I get notified when code M12.569 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code M12.569. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code M12.569?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Orthopedic Joint Procedures of the Knee for Managed Medicaid (MMC), Health and Recovery Plan (HARP), Child Health Plus (CHP), and Essential Plan (EP) Members - (Effective Date - 2027-01-01) 7.01.123

Autologous Chondrocyte Implantation (ACI) - (Effective Date - 2026-10-15) 7.01.38

Seat Lifts and Patient Lifts (CPB 0459, reviewed 2026-07-16)

Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

Extracorporeal Shock-Wave Therapy for Musculoskeletal Indications and Soft Tissue Injuries (CPB 0649, reviewed 2025-10-02)

What insurance policy changes affect code M12.569?

Which payers have updated policy for code M12.569?

How do I get notified when code M12.569 policy changes?

Why do payers change policies for code M12.569?